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Appendix

A. Supplementary Methods
Data and code are on a Github Repository: github.com/katiehampson1978/rabies_PEP_access
Decision Tree Parameters
We used estimates of the risk of developing rabies following a bite by a probable rabid animal (Pinfect) from a data set describing health utilisation and outcomes of bite victims derived from contact tracing in Tanzania. 1 Based on the health outcomes of bite victims who did not receive PEP, the probability of developing rabies following a bite was calculated. The overall probability of rabies transmission from a probable rabid animal bite was estimated based on the proportion of bite victims bitten on different body parts and the risk of developing rabies given the bite site. For the decision tree PSA we simulated this probability using a mixture model from these data. 1 Individuals were assessed for the timeliness of PEP administration, where 'timely' PEP was defined as PEP received on the same day as the bite, and 'late' PEP was received 1 or more days after the bite. Individuals were also assessed for PEP completion, with 3 or more doses considered 'complete' and fewer doses considered 'incomplete'. The probability of timely and complete PEP (>2 vaccine doses, without RIG) preventing rabies (Pprevent1) was estimated to be 1.00 (95% CI: 0.992-1.000), in line with zero deaths from 473 persons bitten by probable rabid dogs that completed timely PEP. The protection provided by imperfect (late or incomplete) PEP (Pprevent2) was based on a subset of these data. 14 deaths were identified from 1005 patients bitten by probable rabid animals that received imperfect PEP, i.e. Pprevent2 = 0.986 (95% CI 0.977-0.992). Nine of these deaths were attributable to delays in initiating PEP and five were associated with timely delivery of just one or two PEP doses only. Published data were extracted for nerve tissue vaccines (NTVs) with complete PEP defined as a minimum of 14 of the 17 daily vaccinations and incomplete PEP defined as <14 vaccinations.
2 The probability of preventing rabies given a complete NTV course (Pprevent3) was 0.99 (95% CI 0.97-0.99) and for an incomplete NTV course (Pprevent4) was 0.94 (95% CI 0.84-0.99). We only considered completeness of NTV courses because no information was provided on timeliness.
Evidence suggests that, even in the absence of RIG, the application of three timely high-quality cell culture or embryonated-egg vaccine doses is highly protective against rabies. 1, 3 Only limited information is available on the protective effect of one or two timely vaccine doses (1 death from 51 bites by probable rabid dogs in Tanzania, versus 0 deaths from 124 patients with 3 timely doses). Other data indicates that a single timely vaccine dose is not completely protective (1 death following only a single timely 1st vaccination reported from Haiti, R Wallace personal communication). In general, delays in PEP administration are common and often conflated with incomplete PEP, as a result of high PEP costs and limited availability. 1, 4, 5 In the decision tree we assume that 'imperfect' PEP accounts for both the risk of death from incomplete PEP including patients in receipt of only one or two vaccine doses, and the risk of death from patients who received PEP (complete or incomplete) following a delay of at least one day. Although very rare, rabies deaths may occur despite timely and adequate PEP in the case of direct virus inoculation into a nerve or breakdown of the cold chain.
The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study WHO Rabies Modelling Consortium 6 To estimate baseline health seeking for healthy dog bites (pseek|healthy) we compiled data on reported bite incidence from health facilities from a range of countries. Using a GLMM we identified that bite patient incidence increased with the human development index (regression coefficient 5.4, Standard Error (SE) 2.16, p<0.0001), decreased with the urban proportion of the population (coefficient -3.1, SE 1.5, p<0.05) and increased with free access to PEP (coefficient 1.1, SE 0.44, p<0.05) ( Figure S4 ). We adjusted our estimate of rabies exposure incidence by health seeking behaviour using country or cluster estimates of pseek|rabid to estimate the incidence of patients presenting to facilities due to rabies exposures. Using the data on bite patient incidence we estimated the proportion that were expected to result from rabid animals versus healthy animals to generate predictions of pseek|healthy from our regression together with estimated human and dog populations in each country.
We used country-specific data to inform the baseline probability (scenario 1 status quo) that rabid dog bite victims sought care and that on seeking care bite patients received and completed PEP (Tables S2 & S3) . We assumed that on introduction of improved access, the probability of bite victims seeking, receiving and completing PEP all increased by probability 0.1 (Table 1) . Following the introduction of improved PEP access, we also assumed incremental increases in these probabilities of 0.03 each year up to the maximum values reported in Table  1 . We based our assumptions on data from studies where access to PEP was improved ( Figure  S4 ). In Tanzania PEP was provided for free and given intradermally at selected decentralized health facilities.
1 In Kenya and Chad PEP was provisioned for free at selected health facilities (GAVI Learning Agenda Studies). In Haiti, IBCM was undertaken with counselling to persuade those bitten by suspect rabid dogs to seek PEP. 6 In a mission hospital in Ethiopia PEP was provided for free as well as free accomodation for those travelling for more than one hour to access PEP. 7 Increases of this magnitude (0.1) were observed for health seeking, PEP provision and compliance in comparison to baseline or in contrast to areas without improved PEP access ( Figure S4A ). In some countries compliance was quite low even under improved PEP access, possibly due to awareness that bites were not due to rabid animals but instead due to healthy animals; an expected consequence of IBCM. We also generally observed higher health seeking and PEP provision in countries offering free or heavily subsidized PEP (Bhutan, Philippines, Madagascar, Cambodia), 8, 9 in line with our assumptions ( Figure S4B ). Our analyses of determinants of incidence of bite patients presenting to health facilities further supports our contention that health seeking is higher when PEP is provided for free ( Figure S5 ).
In our calculation of the cost of an investment to improve access to PEP, we assumed PEP costs are supported in all countries where governments do not currently provide free access to vaccine, including those where non-governmental organizations provide PEP or where governments subsidize vaccine but do not provide it free-of-charge (Table S1 ). Reports from several countries that provide free PEP, also suggest limited availability indicating additional support may be required to improve access, however this may be achieved through improved pricing and introductory grants that would come with Gavi investment.
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We explored the influence of different parameters in the decision tree with a one-way sensitivity analysis. For the principal model outputs in scenario 1 (status quo), scenario 2 (increased PEP access) and scenario 4b (mass dog vaccination with improved PEP access) we ran a probabilistic sensitivity analysis (PSA) taking 1000 draws from the parameter distributions (based on 95% confidence intervals) to generate a 95% prediction interval (PrI). For each of these three scenarios, the univariate sensitivity analyses showed that the rabies burden and cost-effectiveness of interventions were most affected by uncertainty in the probability that PEP prevents disease and that exposure results in infection ( Figure S6) ; reduced vaccine efficacy increases deaths while behavioural changes such as more prompt and thorough wound washing could reduce deaths. Generally, for the scenarios with improved PEP access the uncertainty in rabies burden reduced for all parameters. Under mass dog vaccination the sensitivity analyses indicated greater uncertainty in estimates of PEP cost-effectiveness associated with all parameters except for the incidence of bites by healthy dogs. The influence of the key intervention parameters (Pseek, Preceive, Pcomplete) was also explored for low and high alternatives ( Table 2 ).
Dynamic Transmission model
To characterise rabies dynamics, we used a fully stochastic model parameterised from data on natural rabies infections in domestic dogs in Tanzania adapted from previously published models.
10 This comprised an individual-based model (IBM) of rabies transmission ( Figure S7 ). Rabies transmission or susceptibility in dogs is neither age-nor sex-dependent; however, since domestic dog populations have high birth and death rates, and resulting population turnover rapidly reduces population immunity from vaccination, dog demography was included. We simulated demographic processes (births and deaths) using a Gillespie algorithm.
We fitted the IBM using Approximate Bayesian Computation to rabies incidence data for 2002-2015 from Serengeti district, Tanzania (dog population ~60,000) to characterise the functional form and spatial dependency of transmission. We implemented village-level dog vaccination campaigns within the model according to data on the location, timing and numbers of dogs vaccinated in Serengeti District. The modelling assumptions are illustrated in Figure S7 . The model with the best fitting parameters corresponded to largely density-independent transmission with approximately 50 incursions per year (although the majority of these did not lead to secondary cases). The performance of post-hoc projections given initial conditions provided confidence that rabies dynamics were fully captured. Key life-history parameters for rabies (R0, incubation period, infectious period, duration of vaccine-induced immunity, per capita exposures) are expected to be consistent across populations 11 assuming the use of high quality vaccines and analyses of epidemiological data including outbreak trajectories from a range of dog densities and landscapes are consistent with the simulated dynamics. [10] [11] [12] Simulations from this model in the absence of mass dog vaccination showed that an average incidence of approximately 1% was necessary in order to maintain transmission. Typical confidence intervals were +/-25% of the point estimate. Rather than use exact values from this The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study WHO Rabies Modelling Consortium 8 (currently unpublished) model that is specific to Tanzania, we used the model to characterise the incidence at 1% (range 0.75% to 1.25%) and used this in scenarios 1-3 of the decision tree.
For the purposes of sensitivity analysis and robustness testing, we considered the following alternative conditions: increasing and decreasing contact rates by 5% with respect to baseline and three realistic levels of vaccination coverage with baseline dog population turnover ( Figure  S8 ). In Gavi-eligible countries we expect dog lifespans to generally be short. For the baseline dog population turnover we therefore assumed a mean life expectancy of 25.8 months as estimated in Tanzania. 13 We also investigated a slower rate of dog turnover. We computed turnover for four communities in South Africa and Indonesia as weighted averages of months until loss from cohort, corrected for starting age.
14 In these four communities, dogs lived longer than in Tanzania. We used the community with the slowest turnover, Antiga (Bali, Indonesia) as an alternative, with mean life expectancy of 35.8 months.
For scenario 4, we applied annual mass dog vaccination campaigns commencing after month 36 of the simulation. The three alternative coverage levels that we investigated consisted of the observed vaccination data recorded for Serengeti district, a low coverage alternative using vaccination data from a year when dog vaccinations campaigns were not well implemented (2005) , and a high coverage alternative from a year with well implemented campaigns (2015). For these alternatives, post-campaign coverage was 52% (baseline), 35% (low coverage) and 60% (high coverage) based on post-vaccination transect estimates. We assumed the use of high quality dog rabies vaccines providing lifelong immunity (>2.5 years) administered to dogs of all ages and health.
15 Declines in population immunity were therefore driven by population turnover rather than waning of vaccine-induced immunity. We incorporated spatial heterogeneity in coverage repeated over campaigns, as hard-to-reach populations tend to be consistently missed during campaigns. We assumed that annual campaigns preferentially target dogs that are already vaccinated, in line with anecdotal evidence, leading to conservative coverage levels. To simulate the effect of coordinated vaccination across contiguous populations we modelled a declining rate of incursions with time, using a three-month lag and a cubic function of the vaccinated-to-unvaccinated case ratio (i.e. ratio of number observed under vaccination relative to the unvaccinated baseline) in the preceding 45-day window. We simulated 100 realisations for each alternative condition and used the resulting trajectories in scenario 4 of the decision tree.
We examined the sensitivity of the epidemiological model to uncertainty in parameters. Uncertainty in transmission had a large effect on the incidence of dog rabies whereas the effect of demographic uncertainty, specifically the turnover of dog populations, was negligible ( Figure  S8 ). Improved dog vaccination coverage coordinated across regions to prevent incursions more rapidly controlled dog rabies ( Figure S8 ) whereas lower coverage and lack of coordination prolonged rabies persistence. This would be expected given incursions from neighbouring countries or poor/patchy coverage in part of a country. These changes to the epidemiological model would translate in corresponding increases in human rabies deaths and use of PEP. Refined dog population estimates would also affect the magnitude of estimates of rabies burden and PEP use and the lack of data from different countries on the size of dog populations limits The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study WHO Rabies Modelling Consortium our ability to more accurately project the impact of interventions (both dog vaccinations and PEP access). Nonetheless, our conclusions remain consistent across the plausible range of parameter values that we modelled. The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study WHO Rabies Modelling Consortium
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Figure S4: Comparison of health seeking, PEP provision and PEP compliance under different levels of PEP access. Comparing estimates in A) settings following interventions to improve access to PEP and B) in countries where PEP is provided for free or is heavily subsidised versus countries whether patients must pay for PEP. Further details of studies are provided in the Appendix (Supplementary Methods -Decision tree parameters).
Figure S5. Predictors of the incidence of bite patients presenting to health facilities from a range of countries. Bite patient incidence predicted from our regression coefficients is shown in relation to access to PEP (provided free of charge versus paid for by the patient) and national metrics for A) the Human Development Index and B) the proportion of the population in urban settings. Envelopes show 95% Confidence intervals.
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Figure S8: Time series of dog rabies incidence under different modelling assumptions. A) Baseline with no dog vaccination (scenarios 1-3, light grey), versus coordinated mass dog vaccination from year 2 (scenario 4), versus dog vaccination with ongoing incursions from neighbouring areas (for sensitivity analyses); B) Baseline with no dog vaccination compared to high and low transmission; C) Coordinated mass dog vaccination compared to high and low vaccination coverage alternatives and D) Coordinated dog vaccination with fast versus slow turnover of the domestic dog population. Median incidence and 95% prediction intervals are shown (grey envelopes).
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